Related Experiment Video
Updated: Feb 18, 2026

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors
Alina Nicoara1, David Ruffin1, Mary Cooter1
1Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Insights
Primary graft dysfunction (PGD) after heart transplantation (HT) affects 31% of patients. Key risk factors include longer ischemic times and specific recipient characteristics, highlighting the need for targeted interventions to improve outcomes.
Area of Science:
- Cardiology
- Transplantation Medicine
- Immunology
Background:
- Heart transplantation (HT) is a life-saving procedure, but primary graft dysfunction (PGD) remains a significant complication.
- Donor and recipient demographics are evolving, potentially impacting PGD incidence.
Purpose of the Study:
- To evaluate the incidence, trends, and risk factors associated with PGD in adult heart transplant recipients.
- To identify specific demographic and clinical variables linked to PGD development.
Main Methods:
- Retrospective analysis of 317 adult patients undergoing HT between January 2009 and December 2014.
- Utilized International Society for Heart & Lung Transplantation (ISHLT) criteria for PGD categorization.
- Assessed clinical and demographic factors for independent association with PGD, including time-trend analysis.
Main Results:
- PGD occurred in 31% of patients (99/317).
- Independent risk factors for PGD included prolonged ischemic time, African American race, and pretransplantation amiodarone use.
- No significant change in PGD incidence over the study period, but increased amiodarone use was noted.
- 30-day mortality was significantly higher in patients with PGD (6.06% vs. 0.92%).
Conclusions:
- PGD incidence remains high despite advancements in heart transplantation.
- Identifying and understanding risk factors like ischemic time and recipient characteristics is crucial for developing targeted interventions.
- Further research is needed to mitigate PGD and improve post-transplant outcomes.
Abstract:
Changes in heart transplantation (HT) donor and recipient demographics may influence the incidence of primary graft dysfunction (PGD). We conducted a retrospective study to evaluate PGD incidence, trends, and associated risk factors by analyzing consecutive adult patients who underwent HT between January 2009 and December 2014 at our institution. Patients were categorized as having PGD using the International Society for Heart & Lung Transplantation (ISHLT)-defined criteria. Variables, including clinical and demographic characteristics of donors and recipients, were selected to assess their independent association with PGD. A time-trend analysis was performed over the study period. Three-hundred seventeen patients met inclusion criteria. Left ventricular PGD, right ventricular PGD, or both, were observed in 99 patients (31%). Risk factors independently associated with PGD included ischemic time, recipient African American race, and recipient amiodarone treatment. Over the study period, there was no change in the PGD incidence; however, there was an increase in the recipient pretransplantation use of amiodarone. The rate of 30-day mortality was significantly elevated in those with PGD versus those without PGD (6.06% vs 0.92%, P = .01). Despite recent advancements, incidence of PGD remains high. Understanding associated risk factors may allow for implementation of targeted therapeutic interventions.
More Related Videos
12:40A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia
Published on: September 28, 2022
09:25An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
Published on: May 8, 2020
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction